Huiping Li

18PUBLICATIONS
15CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Diagnostic radiographyHaematological tumoursPredictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Aug 26, 2026
Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer: Real-World Outcomes and Treatment Transition Patterns in a Chinese Cohort.

|Jan 24, 2025
Efficacy and safety of JMT103 in patients with bone metastases from solid tumors: A randomized Phase Ib clinical trial.

Ran Ran, Hongtao Li, Tao Sun

|May 21, 2024
Abemaciclib plus endocrine therapy versus chemotherapy after progression on prior palbociclib in HR+/HER2- metastatic breast cancer: A single center real-world study in China.

Hanfang Jiang, Jianxin Zhong, Jing Wang

|May 06, 2024
Effectiveness of gonadotropin-releasing hormone agonists for ovarian function suppression in premenopausal patients with hormone receptor-positive breast cancer: a retrospective single-center real-world study.

Yifei Chen, Ruyan Zhang, Ying Yan

|Mar 23, 2024
Persistence of peripheral CD8 + CD28- T cells indicates a favourable outcome and tumour immunity in first-line HER2-positive metastatic breast cancer.

Xiaoran Liu, Xiangming Cheng, Feng Xie

|Jan 06, 2024
Variant allele frequency in circulating tumor DNA correlated with tumor disease burden and predicted outcomes in patients with advanced breast cancer.

Jianxin Zhong, Hanfang Jiang, Xiaoran Liu

Pageof 3

Frequent Collaborators

3 joint publications

Hanfang Jiang

2 joint publications

Xiaoran Liu

2 joint publications

Yaxin Liu

1 joint publications

Hao Liao